Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience

被引:0
作者
Oscar Epis
Cinzia Casu
Laura Belloli
Emanuela Schito
Davide Filippini
Marina Muscarà
Eleonora Bruschi
机构
[1] Niguarda Ca’ Granda Hospital,Rheumatology Unit
来源
Rheumatology International | 2015年 / 35卷
关键词
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Clinical Remission; Tocilizumab; Disease Remission;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1569 / 1570
页数:1
相关论文
共 16 条
[1]  
Patel AM(2010)Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy Drug Des Dev Ther 4 263-278
[2]  
Moreland LW(2014)Intravenous tocilizumab: a review of its use in adults with rheumatoid arthritis BioDrugs 28 75-106
[3]  
Dhillon S(2014)Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors Biologics 8 141-153
[4]  
Tanaka T(2014)Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity Clin Exp Rheumatol 32 390-394
[5]  
Hishitani Y(2013)Imaging in rheumatology: ultrasafe + ultrasure = ultrasound Rheumatol Int 33 1901-1903
[6]  
Ogata A(undefined)undefined undefined undefined undefined-undefined
[7]  
van Herwaarden N(undefined)undefined undefined undefined undefined-undefined
[8]  
Herfkens-Hol S(undefined)undefined undefined undefined undefined-undefined
[9]  
van der Maas A(undefined)undefined undefined undefined undefined-undefined
[10]  
van den Bemt BJ(undefined)undefined undefined undefined undefined-undefined